2021 共识建议:血友病患者肌肉注射COVID-19疫苗

2021-04-15 国外血液科相关专家小组 Hamostaseologie.2021 Apr 15.

目前可用的COVID-19疫苗被批准用于肌肉注射,皮下注射可能无法确保疗效。本文主要针对血友病患者接种COVID-19疫苗的相关内容提供指导建议。

中文标题:

2021 共识建议:血友病患者肌肉注射COVID-19疫苗

英文标题:

Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia

发布日期:

2021-04-15

简要介绍:

目前可用的COVID-19疫苗被批准用于肌肉注射,皮下注射可能无法确保疗效。本文主要针对血友病患者接种COVID-19疫苗的相关内容提供指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 共识建议:血友病患者肌肉注射COVID-19疫苗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=44f991c00209e538, title=2021 共识建议:血友病患者肌肉注射COVID-19疫苗, enTitle=Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia, guiderFrom=Hamostaseologie.2021 Apr 15., authorId=0, author=, summary=目前可用的COVID-19疫苗被批准用于肌肉注射,皮下注射可能无法确保疗效。本文主要针对血友病患者接种COVID-19疫苗的相关内容提供指导建议。, cover=https://img.medsci.cn/2021515/1621065470945_2020535.jpg, journalId=0, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Thu Apr 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>目前可用的COVID-19疫苗被批准用于肌肉注射,皮下注射可能无法确保疗效。本文主要针对血友病患者接种COVID-19疫苗的相关内容提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1541, tagName=血友病), TagDto(tagId=103666, tagName=COVID-19疫苗)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=35, categoryName=预防与公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1541, guiderKeyword=血友病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8658, appHits=35, showAppHits=0, pcHits=363, showPcHits=8623, likes=0, shares=5, comments=3, approvalStatus=1, publishedTime=Sat May 15 16:11:29 CST 2021, publishedTimeString=2021-04-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 15 15:58:05 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 15:40:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 共识建议:血友病患者肌肉注射COVID-19疫苗.pdf)])
2021 共识建议:血友病患者肌肉注射COVID-19疫苗.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=966098, encodeId=1cb8966098d5, content=又长了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f57c5479109, createdName=荼靡3333333, createdTime=Sun May 16 21:53:20 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965896, encodeId=0d43965896db, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71695502309, createdName=ms4000000212072525, createdTime=Sat May 15 20:35:33 CST 2021, time=2021-05-15, status=1, ipAttribution=)]
    2021-05-16 荼靡3333333

    又长了新知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=966098, encodeId=1cb8966098d5, content=又长了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f57c5479109, createdName=荼靡3333333, createdTime=Sun May 16 21:53:20 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965896, encodeId=0d43965896db, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71695502309, createdName=ms4000000212072525, createdTime=Sat May 15 20:35:33 CST 2021, time=2021-05-15, status=1, ipAttribution=)]
    2021-05-15 ms4000000212072525

    太好了

    0